A B STRA CT Multidrug resistance (MDR) mediated by overexpression of the MDR protein (P-glycoprotein) has been associated with intracellular alkalinization, membrane depolarization, and other cellular alterations. However, virtually all MDR cell lines studied in detail have been created via protocols that involve growth on chemotherapeutic drugs, which can alter cells in many ways. Thus it is not clear which phenotypic alterations are explicitly due to MDR protein overexpression alone. To more precisely define the MDR phenotype mediated by hu MDR 1 protein, we co-transfected hu MDR 1 cDNA and a neomycin resistance marker into LR73 Chinese hamster ovary fibroblasts and selected stable G418 (geneticin) resistant transfectants. Several clones expressing different levels of hu MDR 1 protein were isolated. Unlike previous work with hu MDR 1 transfectants, the clones were not further selected with, or maintained on, chemotherapeutic drugs. These clones were analyzed for chemotherapeutic drug resistance, intracellular pH (pHi), membrane electrical potential (Vm), and stability ofMDR 1 protein overexpression. LR73/hu MDR 1 clones exhibit elevated pH i and are depolarized, consistent with previous work with LR73/mu MDR 1 transfectants (Luz, J.G.L.Y. Wei, S. Basu, and P.D. Roepe. 1994. Biochemistry. 33:7239-7249). The extent of these perturbations is related to the level of hu MDR 1 protein that is expressed. Cytotoxicity experiments with untransfected LR73 cells with elevated pHi due to manipulating percent CO 2 show that the pHi perturbations in the MDR 1 clones can account for much of the measured drug resistance. Membrane depolarization in the absence of MDR protein expression is also found to confer mild drug resistance, and we find that the pH~ and V,1 changes can conceivably account for the altered drug accumulation measured for representative clones. These data indicate that the MDR phenotype unequivocally mediated by MDR 1 protein overexpression alone can be fully explained by the perturbations in V m and pH i that accompany this overexpression. In addition, MDR mediated by MDR protein overexpression alone differs significantly from that observed for MDR cell lines expressing similar levels of MDR protein but also exposed to chemotherapeutic drugs.
INTRODUCTION
Elucidation of the molecular mechanism of multidrug resistance (MDR) l protein-mediated multidrug resistance is a key goal of cancer pharmacology as well as membrane transport physiology. Recent analysis of MDR protein function (Bornmann and Roepe, 1994; Luckie et al., 1994; Luz et al., 1994; Reutz and Gros, 1994; Hardy et al., 1995; Shapiro and Ling, 1995) and other data (Wadkins and Houghton, 1993; Mayer et al., 1985a, b; Mayer et al., 1986; Praet et al., 1993; Wadkins and Houghton, 1995; Wei et al., 1995; Wadkins and Roepe, 1996) suggest that the mechanism for altered drug retention and resistance in MDR cells is more complex than initially thought (Dane*, 1973) . First, a distinction should be made between phenotypic features that are unequivocally mediated by overexpression of MDR protein and those that may be mediated by other events due to exposing cells to chemotherapeutic drugs (Roepe, 1995) . With a few exceptions (Guild et al., 1988; Devauh and Gros, 1990; Luz et al., 1994) analysis of MDR protein function has been done with cells selected or maintained on potent chemotherapeutic drug(s). These drugs have a variety of complex effects, thus the precise description of the MDR protein-mediated MDR phenotype remains vague. This greatly clouds discussions of MDR protein function. For example, most model MDR cell lines exhibit -> 10Z-fold levels of drug resistance, but MDR protein overexpression per se has not yet been associated with particularly high (>10-fold) levels of drug resistance (Guild et al., 1988; Devault and Gros, 1990) . Thus, most studies (including analysis of MDR protein mutants) have likely examined behavior that is at least in part due to drug exposure rather than MDR protein overexpression. It is critical that MDR protein be studied using "pure" transfectants that have not been exposed to chemotherapeutic drugs before analysis.
A vigorously championed model for MDR protein is that it acts as a drug pump, coupling hydrolysis of adenosine 5'-triphosphate (ATP) to direct movement of drug out of a cell against a concentration gradient Sharom et al., 1993; Ruetz and Gros, 1994; Shapiro and Ling, 1995) . However, verification of predicted thermodynamic and kinetic features of putative drug pumping has been difficult to obtain (Roepe, 1992; Bornmann and Roepe, 1994; Shapiro and Ling, 1995; Roepe et al., 1996) . This has led to (a) more involved models such as the "flippase" (Higgins and Gottesman, 1992) or "vacuum cleaner" (Gottesman and Pastan, 1993) models, which attempt to account for the observed unusual thermodynamic and kinetic features or (b) alternative "indirect" models for how overexpression of MDR protein could promote resistance to hundreds of structurally divergent compounds without invoking direct active transport (e.g., the "altered partitioning model," see Roepe, 1995; Wadkins and Roepe, 1996) . A third model is the "dual function" model in which the protein alternates between C1-channel or channel regulator and drug pump conformations; a fourth is the ATP channel hypothesis (Abraham et al., 1993) . The ATP channel model implies that drug resistance may be due to changes in pHi and/or Vm triggered by increased extracellular ATP (Huang et al., 1992; E1-Moatassim et al., 1992) , presumably via a purinergic receptor pathway (Al-Awqati, 1995) .
Since MDR cells exhibit decreased accumulation of many dozens of structurally divergent compounds, any permutation of a pump model envisions that MDR protein is an extraordinary enzyme that violates the law of enzyme specificity. Also, recent studies (Sharom et al., 1993; Reutz and Gros, 1994; Schlemmer and Sirotnak, 1994) that measure putative MDR protein-catalyzed drug pumping yield very slow estimated turnover at reasonable concentrations of drug, 2 as well as very unusual and highly variable ATP hydrolysis:drug translocation stoichiometries. 3 Because of these and other difficulties '-' The vast majority of interpretable drug transport measurements using cells, vesicles or proteoliposomes have analyzed transport of 10 ~ to 10 6 M levels of drug. At concentrations above several p.M, drugs in the "MDR spectrum" form aggregates, and/or exhibit other complex behavior. 10 ~ to 10 _4 M concentrations of these drugs and other agents believed to be "pumped" by MDR protein can cause significant disruption of lipid structure (see Wadkins and Houghton, 1993) that greatly complicates analysis of transport. It is difficult to interpret the significance of drug translocation kinetics at concentratinns greater than several I~M. 3 The coupling principle states that a defined stoichiometry of energy consumption:substrate translocation (in this case, ATP hydrolysis: drug translocation) exists for any pump. For ATP-coupled pumps, summarized elsewhere (Roepe, 1995; Roepe et al., 1996; Wadkins and Roepe, 1996) , it is difficult to visualize how this measured translocation activity (be it pumping, "flipping," or "vacuuming") could compete with passive diffusion to lower drug accumulation under initial rate conditions as is typically observed (see Hammond et al., 1989; Stein et al., 1994; Robinson and Roepe, 1996) , or how the putative pump couples ATP hydrolysis to drug translocation. Demant et al. (1990) estimated the kinetic requirements of a drug pump necessary to decrease accumulation of drugs in MDR cells, and these estimates are orders of magnitude higher than the putative drug pumping measured with vesicles (Ruetz and Gros, 1994; Schlemmer and Sirotnak, 1994) or proteoliposomes (Sharom et al., 1993; Shapiro and Ling, 1995) . Thus, along with the lack of specificity, significant kinetic and thermodynamic "dilemma" are revealed when attempting to reconcile the pump hypothesis with available data and theory.
Other data suggest the MDR phenotype is, at least in part, due to pHi and/or membrane potential (Vm) changes that accompany MDR protein overexpression (Roepe, 1995) . Translocation and retention of chemotherapeutic drugs are influenced by small perturbations in pH~ or Vm (Mayer et al., 1985a, b; Mayer 1986; Praet et al., 1993; Simon et al., 1994; Wadkins and Roepe, 1996) and perturbations of similar, if not greater magnitude typically occur in MDR cells (Roepe, 1995) . In contrast to these data, one study reports no change in pHi for a hu MDR 1 transfectant further selected with adriamycin (Altenberg et al., 1993) . However, this study did not examine V .... and it has been shown (Wei et al., 1995) that depolarization is sufficient to confer MDR. Also, the cells studied by Altenberg et al. were not analyzed for MDR protein expression by immunoblot. This caveat is important, since MDR protein overexpression can be unstable in transfectants (Luz et al., 1994, and RESULTS) and drug resistance per se in drug selected cells is no guarantee of a MDR protein-mediated MDR phenotype. Again, drug selection of model cell lines complicates analysis.
The altered partitioning model envisions that these pH~ and Vm perturbations alter diffusion/retention of chemotherapeutic drugs via several overlapping mechanisms (Roepe, 1995; Wadkins and Roepe, 1996) . It is unknown how these perturbations occur, but there are several possibilities. For example, although there are also conflicting data (Ehring et al., 1994) , a variety of reports describe anomalous CI-transport in MDR cells these stoichiometries are typically between 1:1-1:3. Examination of recent drug transport data reveals that extremely high and widely dit: ferent ATP hydrolysis:drug translocation stoichiometries can be calculated in the specific case of MDR protein-mediated drug translocation (see Roepe, 1995; Roepe et al., 1996) . Hardy et al., 1995) and are thus consistent with the altered partitioning model, since V~ could be perturbed by changes in C1-permeability, Chemotherapeutic drug selection of cells analyzed for Cl-transport may be responsible for discrepancies in the reported data. Another suggestion (AI-Awqati, 1995; Schwiebert et al., 1995) is that ABC (ATP-binding cassette) transporters indirectly modulate ion conductances (which would then influence V,n and/or pHi) through an autocrine mechanism dependent upon ATP export. However, this model has recently been strongly challenged (Li et al., 1996; Reddy et al., 1996) via studies with purified CFTR protein. Other analysis (Roepe et al., 1993; Luz et al., 1994) has revealed paradoxical phenomena such as reduced AE (anion exchange or C1-/HCO3-exchange) activity concomitant with increased AE expression in MDR cells. If some version of an altered partitioning model is entertained, it is important to deduce which pHi/V m alterations are unequivocally due to MDR protein overexpression, and also how they occur.
In devising additional experiments, it is critical to realize that most model MDR cell lines have been created via protocols that include growth on chemotherapeutic drugs, which induce many phenomena. Although MDR transfectants are in theory an improvement, almost all of these have also been grown in the presence of chemotherapeutic drug (Choi et al., 1988; Lincke et al., 1990; Gros et al., 1991; Currier et al., 1992; Loo and Clarke, 1993; Stein et al., 1994; Beaudet and Gros, 1995) . To resolve remaining questions, new experimental systems are required, and detailed biophysical analysis of these is essential.
Therefore, we have created hu MDR 1 transfectants expressing variable levels of MDR protein without exposing the cells to chemotherapeutic drugs. We have analyzed their pHi, Vm, drug resistance, and other traits. The data better define the MDR protein-mediated MDR phenotype and suggest that measured V m and pHi changes are sufficient to promote drug resistance and altered drug accumulation unequivocally due to MDR protein overexpression alone.
MATERIALS AND METHODS

Materials
2',7'-bis (carboxyethyl)-5, 6-carboxyfluorescein (BCECF), the oxacarbocyanines 3,3' diethyloxacarbocyanine iodide (diOC2(3)), 3,3' dipentyloxacarbocyanine iodide (DiOC5 (3)), and 3,3' diheptyloxacarbocyanine iodide (DiOC7(3)), nigericin, valinomycin and the dialkylaminonapthalene pyridinium styryl dye di-4-ANEPPS were purchased from Molecular Probes (Eugene, OR) and used without further purification. 4-acetamido-4'-isothiocyanato stilbene-2-2'-disulfonic acid (SITS), colchicine, and verapamil were from Sigma Chemical Co. (St. Louis, MO), doxorubicin, vincristine, and cyclosporin A were from the Memorial Sloan-Kettering pharmacy (New York, NY), and G418 was from Life Technologies (Grand Island, NY). M1 other chemicals were reagent grade or better, purchased from commercial sources, and used without further purification.
Tissue Culture
Cell lines stably transfected with hu MDR 1 cDNA were created by transfecting a mixture of two plasmid constructs, one harboring a neomycin resistance gene (pSVDNAneo obtained from Invitrogen Corp., San Diego, CA), and the other the hu MDR 1 cDNA cloned behind a cytomegaloviral promoter (plasmid pMDR1), at a 1:10 molar ratio via the CaPO4 precipitation method. The open reading frame of MDR cDNA has been sequenced and, with the exception of a silent Set 180 point mutation, no differences relative to that published (Chen et al., 1986) have been found. Mass populations of LR73 transfectants were selected with 500 tzg/ml active G418; a concentration that did not allow negative control transfectants (pMDR1 without pSVDNAneo) to suiwive. Over 100 G418 resistant colonies were then replica-plated in 24-well plates. One well of a pair was grown in the presence of 100 ng/ml doxorubicin. The second well was grown in the presence of G418 without any chemotherapeutic drug. From an initial screen of over 100 G418 resistant LR73 clones, 5 that smwived doxorubicin selection were found to express MDR protein (see below). An additional 3 overexpressors were found among 35 additional colonies from a second transfection. Thus, we find that a low frequency (<10%) of G418 resistant clones apparently overexpress significant MDR 1 protein. After screening, cells from the sister "G418-only" wells were propagated in the presence of G418 only and screened for MDR protein expression via western blot (see RESULTS). These clones were, with one exception (see below), never exposed to any chemotherapeutic drug before analysis. Cells analyzed for Vm or pHi (see below) were propagated in the absence of G418 for not more than 10 d. These conditions did not measurably reduce levels of MDR protein. Stock cultures of the stable transfectants were frozen in liquid nitrogen and resuscitated as needed.
In one instance, hu MDR 1 clone #27 was exposed to chemotherapeutic drug before analysis (described in the legend to Table II) for the specific purpose of determining how this exposure effected the drug resistance profile (see RESULTS).
LR73 transfectants were grown at 37~ in a 5% CO,, atmosphere in Dulbecco's modified Eagle's (DME) medium supplemented with 10% FCS, 200 U/ml of penicillin, and 100 ~g/ml of streptomycin. For mass cell population V m measurements or Western blot analysis (see below), they were harvested by trypsinization, washed, and gently resuspended in fresh media.
For single-cell photometry analysis of pHi and Vm, the cells were grown as above but on glass coverslips (18 ram2/0.11 mm thick; Corning Glassworks, Coming, NY) immobilized in standard tissue culture plates with a dab of autoclaved silicon vacuum grease (Dow-Corning, Midland, MI). Coverslips were kept in media at 37~ and 5% CO 2 until immediately before mounting on a perfusion chamber (see single-cell photometry below and Luz et al., 1994; Wei et al., 1995) .
Drug Resistance
Resistance was assayed by colony formation as described (Wei et al., 1995) . Surviving colonies >50 cells were scored visually. Plating efficiency at each drug concentration was analyzed in duplicate. Resistance was also assayed by growth inhibition as described .
Drug Accumulation
Measurement of anthracycline, vinca alkaloid, or colchicine accumulation was essentially as described with some modifications. We assayed '3H-daunorubicin, 3H-vinblastine, or 3H-colchicine (New England Nuclear, Boston, MA) accumulation by plating cells in six well plates (5.0 • 104 cells/ well initial density), incubating the plates in normal DME medium at 37~ and 5% CO~ (see tissue culture, above) for 3 d until they reached 75% confluency, and then exposing them to the :~H analogues (50 nM, 200 txCi/mM for :SH-daunorubicin; 50 nM, 75 IxCi/mM for :~H-vinblastine; 50 nM, 200 IxCi/mM for ~H-colchicine) for exactly 60 min. Drug-containing medium was then aspirated; cells were washed once with cold PBS to remove non-internalized drug, and cells then were harvested by trypsinization. Trapped radioactivity was measured by liquid scintillation spectrometry. Nonspecific drug association (zero-time uptake) was measured by incubating an identical number of cells in medium pre-chilled to 4~ Cell number was counted using a hemocytometer, and aliquots of the collected cells were assayed for protein content by the Bio-Rad assay (Bio-Rad Laboratories, Richmond, CA). Drug accumulation was expressed as both picomoles drug/ microgram total cell protein and nM internalized drug (see Table I for cell volumes). Protein content per cell was not dramatically different for the different cell lines. Accumulation was measured in triplicate for each cell line in each accumulation assay, and the results from three such assays were averaged to yield the data shown in results (SE <10%). Data is expressed as a percentage of accumulation, with values for LR73/neo controls defined as 100% accumulation (see Fig. 11 in Results).
Pulse Elevation of pH i and Short Exposure Cytotoxicity Assays
We wished to assay chemotherapeutic drug resistance for cells with alkaline pH~ that did not express measurable MDR protein. Thus, to elevate pH i of LR73 cells, they were plated at a density of 10~/100 cm'-' and grown overnight at 5% CO,., in normal DME medium initially harboring 44 mM HCO!~ . They were then shit~ed to a 10% CO,., atmosphere, which causes acidification of the medium (see Wei and Roepe, 1994) . Milder acidification of pH~ accompanies this "CO,, pulse" (see RESUI~TS). Within 36--48 h the pH i acidification plateaus, and the cells then nearly recover pH i (see RESULTS). If the conditioned cells are then placed back in a 5% CO,, atmosphere in the presence of fresh pre-equilibrated media, pH~ "overshoots" and is ~0.15-0.22 units alkaline, relative to normal resting pH i, for ~12-24 h (see RFSULTS). Alter this time, the cells "re-adapt" and return to normal pHi.
Because the cells are alkaline for only a short time, we could not measure resistance for alkaline cells via colony formation or growth inhibition assays, since these require days of growth in the presence of the drugs. Therefore, we de~dsed "short pulse" cytotoxicity assays. In these experiments, any drug resistance may be underestimated, since cytotoxic actions of chemotherapeutic drngs are not necessarily analogous to their growth inhibito D, actions. MDR protein may confer resistance to both.
Cells were harvested by nTpsinization, washed in fresh media pre-equilibrated in a 5% CO,_, atmosphere, and 1.0 • 10 r' aliquots were resuspended in 1 ml of fresh 5% COe-equilibrated media harboring different concentrations of drug (see aZSUI,TS). The cell suspensions were tmnbled in eppendorf tubes in a 5% CO.2 atmosphere, and the cells were collected, washed in fresh 5% CO,e-equilibrated media, and then 2 • 104 aliquots were plated ill each of four wells of a 96-well plate. The plates were grown for 3 d in an atmosphere of 5% CO u, and then stained with clTstal violet, after which the cells were solubilized, and dye was quantitated with an ELISA reader (see Wei and Roepe, 1994) . In separate experiments we verified that the protein content/cell was the same for the different cell preparations. Four determinations at each drug concentration were then averaged, and the results fi'om four such assays (16 determinations in all) were averaged (see al,:-
SUI,TS).
Similar experiments were also performed at different [K+] ,, to test the effect of altered Vm (see aEst~I,TS) on drug resistance. Cells were cultured at 5% CO2, washed in DME media harboring either 127 mM Na+/15 mM K + or 127 mM K+/15 mM Na + and then tumbled (as above) in the same media plus varied concentrations of chemotherapeutic drugs. Cells were then washed in fresh normal media, plated, grown tor 3 d, and stained as above.
Western Blotting
Western blots were performed using the MDR protein-specific mAb C219 and the enhanced chemiluminescence detection system (Amersham Corp., Arlington Heights, IL) essentially as described but with some modifications in how cell lysates were prepared. Cells were harvested from a 100-cm'-' plate after growth at 5% CO,, to near confluency, washed with PBS, pH 7.3, and stored at -80~ Cells were thawed and lysed in ~200 Ixl cracking buffer (10% glycerol, 1% Triton X-100, 1 mM PMSF, 10 >g/ml leupeptin, 20 mM HEPES). They were then vortexed, incubated at 4~ for 15 rain, and spun in a microcentrifuge (12,000 rpm) at 4~ for 5 min. The supernatant was removed, and 1 txl was assayed with the Bio-Rad protein assay, with BSA as a standard. 100 Ixg of cellular protein was then resolved by sodium dodecyl sulfate-PAGE and blotted to nitrocelhflose overnight at 40 mA constant current . Alter Western blots were performed as described , the autoradiogram was scanned with a 300 dpi scanner (Stratagene Inc., LaJolla, CA). The intensity of bands of interest were normalized to background emission from the blot and quantitated with Stratagene densitometry software using an AST computer.
Fluorescence ,Spectroscopy
Fluorescence spectra were obtained with a Photon TechnoloD, International (South Brunswick, NJ) fluorometer interlaced to a Dell/433L computer. Sample cuvettes were jacketed within an aluminum holder, and temperature was controlled by a circulating water bath. Cell suspensions were rapidly mixed with a magnetic stirrer situated beneath the cuvette. Excitation/emission wavelengths and the other parameters of various experiments may be fonnd in the individual figure legends.
Single-CeU Photometry (SCP) and Measurement of pH~
As described (Luz et al., 1994; Wei et al., 1995) , we have constructed a single-cell photometry apparatus using a Nikon diaphot microscope and a Photon Technology alphascan flnorometer. For BCECF experiments a 510-nm dichroic and a 530-nm bandpass filter was positioned beneath tim stage, and the excitation monochromator was flipped between 439 and 490 nm by the compnter (see Wei et al., 1995) . For carbocymfine experiments, we used a 510 dichroic and a 495 high pass filter under the nilcroscope stage, and the excitation naonochromator was fixed at 465 nm.
Cells were grown on sterile glass coverslips as described above and used >2 but <6 d after plating. Coverslips were incubated with BCECF-AM in DME media for 30 min belore mounting in a perfusion chamber, which provided mfilamellar perfusate flow (Wei et al., 1995) . Aller mounting, cells were continuously perfused with Hank's balanced salt solution (HBSS: 118 mM NaCI, 5 inM KCI, 10 mM glucose, 24.2 mM NaHCO> 1.3 mM CaCI,.,, 0.5 mM MgC1,2, 0.5 mM Na,_,HPO.~, 0.6 mM KHePO,; pH 7.33) equili-brated with 5% CO2 and to 37~ Flow rate was 5 ml/min, and perfusate volume in the perfusion chamber was ~100 ~zl, so buffer over the cells was exchanged within 1-2 s. Uniform BCECF staining was verified by monitoring 490-nm excitation intensity; we did not observe significant differences in BCECF loading for MDR vs. control transfectants (see RESULTS). All buffers harboring HCO~-were continuously purged with 5% CO2 (balance air), and pHo was monitored with an electrode. Exposure to excitation was limited to the time of data collection to limit photobleaching.
Steady-state pHi was computed by averaging 439/490 nm excitation for 12-20 individual cells (data collected 1 cell at a time) perfused with HBSS before the same coverslip was exposed to calibration solution containing nigericin (100 mM KC1, 40 mM NaC1, 20 mM HEPES, 1.5 p,M nigericin) equilibrated to various pH (see Fig. 3 ) and then inserting the averaged value into a quadratic fit to the calibration solution standard curve. Calibration curves were obtained using a "single cell" version of the K+/ nigericin titration approach of Thomas and colleagues (1979) as described (see RESULTS and Luz et al., 1994) , and they were generated for every coverslip used to measure steady-state pHi under physiologic conditions.
Measurement of Electrical Membrane Potential ( V,n)
K+/valinomycin null point titration (Laris and Hoffman, 1986) , using the fast response ratiometric styryl dye di-4-ANEPPS (Montana et al., 1989) , was used to quantitatively estimate Vm as described in detail previously (Roepe et al., 1993; Luz et al., 1994; Wei et al., 1995) . We have recently published the results of a double-blind analysis (Wei et al., 1995) wherein V m measured for CFFR overexpressors by electrophysiology techniques (zero current clamp potential recorded within 10 s of establishing whole cell configuration; see Stutts et al., 1993 ) was compared to Vm measured by our K+/valinomycin titration protocol. Although the values obtained did not agree exactly, significant differences in V,n between cell lines were easily distinguished by either method, and the general trend in V,n observed in a series of CFTR clones expressing different levels of functional channel was essentially the same via both methods. Contributions to the measured Vm from mitochondria and other organelles as well as variability in the concentration of cell-associated dye are less of a concern with di-4-ANEPPS measurements, and since it is a fast response probe, measurements are made in seconds rather than minutes, avoiding altered dye partitioning within the cell during the valinomycin titration (see also Roepe et al., 1993) . Thus, any postulated pumping of the dye by MDR protein would not, if it even existed, bias the measurements. We compensate for the low di-4-ANEPPS signal by averaging several traces from multiple titrations at each [K+],,. As reported previously (Roepe et al., 1993; Luz et al., 1994) , [K+]i does not vary substantially between MDR and sensitive cells, thus an average value of 160 mM was used to calculate Vm-TO test conclusions from the di-4-ANEPPS experiments, we also measured carbocyanine uptake via single cell photometry. Coverslips were perfused with HBSS, pH 7.30, as described for pH~ measurements above. We then switched to HBSS perfusate containing 500 nM diOCz(3), diOCs(3), or diOC7(3 ) and monitored the increase in cellular fluorescence >510 nm (465-nm excitation) while the cells were under constant perfusion. Wavelength-dependent excitation and emission spectra in the presence or absence of cells verified the respective maxima were not appreciably shifted by binding to cells. HBSS/carbocyanine solutions were prepared immediately before perfusion from a 1 mM stock made in anhydrous DMSO and HBSS pre-equilibrated in 5% COz and to 37~ In some cases, K + was substituted for Na + in the HBSS to depolarize cells (see RESULTS). AS pointed out in a recent paper by Wadkins and Houghton (1995) and as first described by Hoffman and colleagues (Sims et al., 1974) , longer chain length trimethine carbocyanines (diOCv(3)-diOCs(3)) are less responsive to membrane potential than moderate chain length carbocyanines (e.g., diOCs(3)), and in many cell types, decreasing chain length further does not elicit a more Vm-dependent response and may actually decrease the responsiveness of the carbocyanine to V,,, at least as measured by changes in dye partitioning upon treatment with valinomycin. Redistribution should be distinguished from initial accumulation when discussing V,,, probes; both "redistribution" upon changing V,~, and initial accumulation are Vm dependent, and both responses are dye concentration dependent (see Sims et al., 1974; Roepe et al., 1993; Wadkins and Houghton, 1995) . Thus, plotting differences in the rate and/or steady state of accumulation of the different probes for "matched" cell lines (e.g., derivatives of the same parental cell line with similar size) is a legitimate complementary estimate of any difference in membrane potential (see RESULTS). For cells with different Vm, accumulation of longer-chain carbocyanines (relatively non-Vm-dependent at low concentrations) should be similar, and relative probe accumulation should diverge as chain length approaches 5 carbons (i.e., for Vm-dependent probes). A series of experiments, although tedious, will correct for nonspecific effects of dye association that are unrelated to V,n. Accumulation of each carbocyanine was measured for each cell line at least four times using four different coverslips, and the data were averaged (see RESULTS).
Measurement of [K+ li
Cell-associated K + was measured by flame photometry as described (Iversen, 1976; Roepe et al., 1993) . After determining intracellular volume (see below), [K+]i was calculated.
Measurement of lntraeellular Volume (Vii)
Total cell volume was calculated after determining the mean particle size of cell suspensions by the single threshold Coulter method (Kachel, 1990; Roepe et al., 1993) . Intracellular water volume was determined by ratioing 14C-inulin vs. :~H20 dpm as described (Rottenberg, 1979; Roepe et al., 1993) . Table I summarizes characteristics of a series of 6 LR73 pSVDNAneo/pMDR1 transfectants created and isolated as described in MATERIALS AND METHODS. Also included for comparison purposes is similar data for the cell line EX4N7 (Gros et al., 1991) , which is LR73 transfected with mu MDR 1 and a neo r marker and selected with G418 only, as well as data for control transfectants (LR73/neo) which do not express MDR 1 protein but were otherwise treated identically relative to the hu MDR 1 clones. Fig. 1 A presents representative data from Western blot analysis of MDR 1 protein expression in these transfectants and shows that we isolated clones with different levels of MDR protein without subjecting the cells to different levels of chemotherapeutic drug selec- Roepe et al., 1993; Luz et al., 1994) , and drug resistance (by colony tbrmation; see Wei et al., 1995) for LR73-derived hu MDR 1 transtbctants used in the present work, as well as parental LR73 cells and a negative control transfectant also selected with G418. Relative MDR protein is the average of three densitometric determinations from three Western blots; note clone #21 is assigned a value of 1. Fold-resistance was determined by either growth inhibition or colony formation assays and ratioing ICr,0s that were calculated by exponential ties to the data (R z > 0.92 in each case, see Wei el al., 1995 and MATERIALS AND METHODS) . Data shown is the average of two determinations (Wei et at., 1995) . N.D. denotes not done.
RESULTS
Characterization of hu MDR 1 Expression and pHi for Transfectant Clones
tion. Overexpression of nm MDR 1 protein may be unstable in some transfectants; that is, EX4N7 cells cultured for several months in the presence of G418 eventually lose mu MDR 1 protein (Luz et al., 1994) . As shown in Fig. 1 B, we again find this to be the case for some, but not all, hu MDR 1 transfectants. As some clones are passed in the presence of G418, overexpression of MDR protein decreases, and eventually disappears after 14-21 passages. Thus, most subsequent work was performed with cell lines exhibiting stable overexpression (e.g., clones #24, #27, and #95), and overexpression levels were routinely checked every 6-10 passages. We do not find that high level expressors are necessarily less stable with regard to expression over time, in fact, clones #24 and #27 exhibit a very stable phenotype (see Fig. 1 legend) . Levels of overexpression varied from very mild (#21) to quite impressive; clones #24 and #27 exhibit levels of expression that are higher than those found in MCF7/ ADR and 8226/Dox40, breast carcinoma and myeloma cells selected with anthracycline that are ~100-and 65-fold resistant to doxorubicin, respectively (Fig. 1 C) . Expression in #27 and #24 is comparable to that found for LR73/1-1 cells, which are Chinese hamster ovai T fibroblasts transfected with murine MDR 1 and selected with 50 ng/ml vinblastine to ~100-fold resistance to the antimitotic (Gros et al., 1991) and close (within twofold) to the levels found for DC3F-ADX (Biedler and Riehm, 1970) , a Chinese hamster lung fibroblast selected to 10,000-fold resistance to actinomycin D (Fig. 1 C) . Thus, comparing these data to data in Table  I indicates high levels of drug resistance in MDR cells are related more to drug selection than to MDR protein overexpression.
Notably, all hu MDR 1 clones exhibit significant intracellular alkalinization (between 0.21 and 0.35 units) relative to control transfectants (Table I ). The present data showing alkalinization in all six independently derived clones, along with a qualitative relationship between alkalinization and MDR protein expression (see DISCUSSION) shows that hu MDR 1 protein overexpression typically promotes intracellular alkalinization in LR73 cells. Since it has been proposed that the acetoxymethyl ester analogues of probes we have used to measure pH i might be "pumped" by the MDR protein (Homolya et al., 1993) , we have thoroughly examined this possibility. Fig. 2 presents representative BCECF-AM loading and BCECF washout data for hu MDR 1 and control transfectants and documents that BCECF-AM or BCECF pumping does not occur in these transfectants. Furthermore, calibration curves generated as described in MATERIALS AND METHODS reveal that the pHi-dependent behavior of BCECF is virtually identical in the different cell lines (Fig. 3) . That is, even though there are slight differences in the absolute value of 439/490 nm BCECF excitation at various pHi, the shape and slope of the 439/490 nin excitation vs. pH~ cmwes for the different cell lines are indistinguishable. Even if we disregard the data in Fig. 2 and assume BCECF or BCECF-AM is pumped by MDR protein, this pumping function does not compromise our ability to obtain accurate pHi.
Examination of H + Excretion and pH,/pH o Relationships with or without HCO~-
In culturing drug-selected MDR cells over the years, many investigators have noticed that growth media har- (Homolya et al., 1993) , we find that MDR and control transfectants convert very similar levels of BCECF-AM (early time, B) in sinfilar time and exhibit virtually identical rates of BCECF leak (B) that varies between 1 and 5% per h. In well over 100 individual experiments, no statistically significant difference in the level of BCECF-AM loading has been observed for these MDR transfectan~s relative to the parental cells. Along with the observation that the K+/nigericin titration curves for the different cell lines are snperimposable (see Fig. 3 ) these data argue that there is no interaction between BCECF or BCECF-AM and the MDR 1 protein.
boring phenol red turns a more yellow color, relative to the media for control drug-sensitive cells, perhaps indicating a greater production of acid by the MDR cells. Since our clones have alkaline pHi (Table I) , perhaps one explanation for both observations is increased cellular H + effiux. We quantified acid production by ratioing DME media absorbance at 560 and 421 nm at dif- ferent days' growth (Fig. 4) . To correct for mild differences in growth rate, data is plotted vs. cell number. The inset to Fig. 4 shows a calibration cmwe for DME media titrated to different pH. We do not measure significantly increased production of H + for cultures of either clone #24 (Fig. 4, diamonds) or clone #27 (not shown), relative to control cells (Fig. 4, square.s) . Based on this observation, and estimation of the change in pH,, expected for a given increase in the rate of H + efflux, (see legend to Fig. 4) , we conclude that alkalinization of the MDR clones is not likely due to an increased rate of H + effiux from these cells. To further examine pHi regulation, we measured pHi at a variety of pH,, while cells were perfused with buffers with or without variable [HCO:~] (Fig. 5) . We have previously observed (Roepe et al., 1993; Luz et al., 1994; Roepe et al., 1994 ) that cells overexpressing MDR protein exhibit altered HCO~-dependent pHi regulation (i.e., reduced C1 /HCO:~ exchanger activity). As shown, pHi/pH,, relationships obtained in the presence vs. absence of HCO:~ are different for the control cells, whereas they are much more similar for clone #27. These data suggest alkalinization for the MDR clones may be, at least in part, due to perturbation of HCO :~-dependent mechanism (s).
Electrical Membrane Potential Alterations
Along with alterations in phi, importantly, all hu MDR 1 clones were found to be depolarized (Table I) , The decrease in Vm was quantitatively estimated to vary from 8 to 22 mV via K+/valinomycin titration as described (Roepe et al., 1993; Luz et al., 1994) .4
To further test for differences in membrane potential, we analyzed the rate and steady state of oxacarbocyanine uptake for attached cells under constant perfusion. Members of the diOC,,(3) series of oxacarbocyanines differ in their response to membrane potential but only slightly in size (Sims et al., 1974; Wadkins and Houghton, 1995) , and not at all in terms of fluorescence excitation/emission wavelengths. Thus, analysis of the relative uptake of a series of the compounds (see MATERIALS AND METHODS) offers a way to analyze Vm and control for nonspecific effects. (Luz et al., 1994) , data in the inset demonstrate the ability of the single-cell method to distinguish between cells exhibiting significantly different V,~. Clearly, clones exhibiting high levels of MDR protein expression and substantial depolarization via the K+/valinomycin determination ( Table I ) accumulate oxacarbocyanines that are more responsive to V,, (diOC~(3) and diOC~(3), Fig. 6 B and C) at a reduced rate and to a much lower steady state, relative to the control cells, but accumulate diOC7(3) (Fig. 6 A) , which does not respond to Vm vex,/ efficiently at these concentrations (see Sims et al., 1974; Wadkins and Houghton, 1995) , similarly relative to control cells. Also, with one exception (clone #88) the relative uptake of diOC~,(3) for the tRepresentative K+/valinomycin titration traces for I.R73 cells and pure mu MDR 1/LR73 transfectants may be found in I.uz et al. hie-blind comparison of electrophysioh)gic and our K+/valinomycin titration methods has recently t)een published (Wei et al., 1995) . Note that all the cell lines examined are derived t}om a single isolate of the parental LR73 cell line, have ve D' similar size (Table 1) and have V,,, that is dominated by K + conductance (not shown, see Roepe et al., 19.03) . Thus, the most reasonable explanation tor substantially different K~/valinomycin null points (Table 1) Cell density / well FIGURE 4. Plot of DME culture medium pH vs. cell densi W for growing cultures of control (squares) and MDR 1 (clone #24) transfectants (diamonds). Data are fit to exponential equations, (R'-' > 0.91 in each case), and are representative of three separate experiments. The inset shows the change in 560/421 nm absorbance for DME media (equilibrated with 5% CO., and to 37~ titrated to different pH via addition of 5 Ixl aliquots of 0.10 N HC1 (e.g., addition of 0.50 mM H + between each point). Data is fit to a logarithmic equation, R'-' > 0.96. From this calibration curve we can conveniently calculate pH o of the culture medium by visible absorption, as well as the medium buffering capacity at various pH,,, since known amount.s of HC1 were added (13i = ApH/2x[H+]). Even allowing for DME buffering capacity, ifMDR protein directly or indirectly translocated H + at a turnover greater than ~10 H+/MDR protein/s, we should measure a faster acidification for the transfectant culture medium. Using the data in the inset, we calculate the buffering capacity of DME media (between pH 7.33 and 6.93) to be 9.8 raM. We estimate that the minimal pH change that would be reliably detected under these experimental conditions is about 0.05 U/d, and to produce this change the MDR protein present in 10 ~ cells would need to extrude on the order of 10 Is H+/d. Assuming a reasonable site density tor MDR protein, we can eliminate models that envision MDR protein directly or indirectly translocates more than ~10 H+/s. Thus, ifMDR protein is (or stimulates) an H + ATPase, or promotes H + effiux some other way, it has vely slow turnover at the pH i listed in Table I. different clones (Fig. 6 D) appears to follow the same trend as V,, determined by K+/valinomycin titration (Table I) FIC.URE 5. Plot of the relationship between pH~ and pH. for control (A) and hu MDR 1 clone #27 (B) transfectants. The pHi was measured under constant perfusion by SCP as described (see MA-TFRIALS AND METHODS) and pH,, (+0.03 U) was measured for equilibrated perfusate with a pH electrode. Cells were pelfused with buffer for 10 min before initiating the measurements. For each coverslip, we either started with high pH perfusate and proceeded to lower pH, or visa versa, collected pH~ for 20 cells at each pH (with 10 min equilibration time between buffers) and then computed a standard curve using the same coverslip (see Fig. 3 ). We noticed slight differences in pHJpH,, relationships depending upon whether perfusate went from high to low or low to high pH, but compensated for this slight variation by averaging the results from six different experiments with six different coverslips to compute pHi (+_0.07 U) at each pH. (+_0.03 U, error bars omitted for clarity). The open symbols represent data collected under HCO:~-free conditions (perfusion with HEPES buffered saline; 145 mM NaC1, 5 mM KC1, 10 mM glucose, 1.3 mM CaC12, 0.5 mM MgCI~, 20 mM HEPES adjusted to various pH), and the closed symbols represent data collected during constant perfl~sion with HBSS adjusted to different pH by adjusting HCO~ concentration in the medium (at fixed 5% COL_,). The HCO:T concentrations were 10, 24.2, 50, and 75 mM at pH 6.92, 7.30, 7.57, and 7.93, respectively, and tonicity of the medium was kept constant (relative to normal HBSS) by either addition of 14.2 inM or withdrawal of 25.8 or 50.8 mM NaC1, respectively, along with addition of reduced or increased NaHCO:),, respectively (see MATERIALS AND METHODS). Reduction of CI-concentration by 50 mM for HBSS (via substitution with glutamate) does not in and of itself lead to significant changes in pH, for these cells over the time course of the measurements (not shown).
is related to relative MDR protein overexpression. One could conceivably argue that decreased diOC2(3 ) and diOCs(3) uptake is due to outward pumping of the compounds by MDR protein, but it would be surprising if MDR protein pumped compounds as structurally diverse as diOC2(3) and vincristine, but not compounds as similar as diOCT(3) and diOC~(3). Considering all the data together, decreased carbocyanine uptake due to lower V,, is a much more logical explanation.
Resistance of the Clones to Chemotherapeutic Drugs and Chemoreversal
The clones were also analyzed for resistance to the chemotherapeutic drugs doxorubicin (Dox), vincristine (Vncr), and colchicine (Col) ( Table I) . As previously observed for 3T3/mu MDR 1 infectants (Guild et al., 1988) or mass populations of pure LR73/mu MDR 1 transfectants (Devault and Gros, 1990) , drug resistance exhibited by these pure hu MDR 1 transfectants is low compared to MDR 1 overexpressing cell lines that are selected or maintained with chemotherapeutic drugs (see INTRODUCTION and Fig. 1 O. Thus, data in Table I and Fig. 1 Cindicate that exposure to chemotherapeutic drugs must significantly perturb the resistance profile unequivocally attributable to MDR protein overexpression.
To test this idea further, clone #27 was grown in the presence of either doxorubicin (cell line 27D500), vincristine (27V500), or colchicine (27C500) over a period of several weeks to generate three derivative cell lines (see Table II legend). These three "selectants" were then assayed for drug resistance and for relative MDR protein expression as described in Fig. 1 (Table  II) . Interestingly, growth in the presence of either doxorubicin or colchicine not only increased resistance to the "selecting agent," as would be anticipated, but increased resistance to the other two drugs as well. In contrast, growth on vincristine did not increase resistance to the other drugs as significantly. Relative expression of MDR protein increased only slightly (10-30%) for the selectants relative to the transfectant (Table II). For each selectant, the "resistance profile" (rank of preferential resistance to various drugs) changes. For example, 27C500 was similarly resistant to the three drugs, whereas 27D500 was clearly more resistant to Dox, and clone #27 grown in the absence of chemotherapeutic drug more resistant to Vncr.
Studies have shown that several compounds, including the channel blocker verapamil and the immuno- Fold resistance to doxorubicin (dox), vincristine (vncr); and colchicine (col) for three drug exposed derivatives ("selectants") of clone #27, as well as relative MDR protein expression (relative to clone #21, see Table  II ). The three se]ectants were produced by growing clone #27 cells in the presence of either 150 nM Dox, Vncr, or Col for 2 wk, and then 3 wk more in the presence of 500 nM respective drug. These "drug conditioning" conditions should be distinguished from formal selection with chemotherapeutic drug. Resistance was analyzed by growth inhibition assays (see MATERIALS AND METHODS) and relative survivability at 6 concentrations of drug was analyzed in triplicate (see Wei and Roepe, 1994 ; SE for each point <5%). After fitting survivability curves (e.g. as shown in Fig. 7 ) to an exponential (Wei et al., 1995 ; each fit R 2 < 0.92) IC50 for a given drug was calculated, and ratioed vs. 1Cs0 determined for LR73/neo to compnte fold resistance. Relative MDR protein expression is the average of two densitometric scans from a Western blot performed as described in Methods; both LR73 #27 and LR73/neo were also resolved on this gel as an internal calibration.
suppressive agent cyclosporin A, act as chemoreversal agents, meaning they reverse the drug resistance exhibited by MDR cells (Ford and Hait, 1990) . Reversal of resistance at nontoxic doses of chemoreversal agent is not typically complete, and the level of drug resistance mediated by MDR protein is low (Table I) . Also, these compounds compete with chemotherapeutic drugs for nonspecific membrane association (Wadkins and Hougton, 1993) , which might confer chemosensitizing ability independent of MDR protein. For these reasons it is unclear whether chemoreversal agents reverse MDR protein-mediated MDR. Therefore, we tested whether the drug resistance in our transfectants was reversed by verapamil and cyclosporin A. Fig. 7 demonstrates that, indeed, these compounds resensitize LR73/hu MDR 1 #27 to the toxic effects of vincristine. Similar results were obtained for two other clones exhibiting similar levels of hu MDR 1 protein overexpression (data not shown). However, importantly, cyclosporin A was found to be toxic above 2 txM, thus apparent complete "reversal" at 2.5 IxM is due to a combination of reversal effects and cyclosporin toxicity. Similarly, we could not demonstrate complete reversal with nontoxic levels of verapamil (< 10 txM).
Drug Resistance for Fibroblasts with Alkaline pHi or Exposed to High [K+]o
In testing the pHi/Vm altered partitioning model, it is not only critical to determine how much drug resistance is explicitly due to overexpression of MDR pro- Nearly complete "chemoreversal" is seen at nontoxic levels (1 ixM) of cyclosporin A, but sensitization to an extent greater than the transfectant control is seen at 2.5 txM due to toxicity of cyclosporin A at this concentration (hence open squares to the left of the curve for the control). 5 IxM verapamil provides for 60-70% reversal of the resistance due to MDR 1 protein overexpression.
rein, but also whether the extent of alkalinization and/ or depolarization observed is sufficient to lead to the measured drug resistance. Since drug resistance is typically assayed over days in cell culture, but most manipulations of pHi and Vm are only reliable for minutes/ hours (or are toxic thereafter) this is challenging. Analysis of CFTR clones that showed depolarization is sufficient to cause low-level MDR has recently been reported (Wei et al., 1995) . To test whether elevated pHi is sufficient to cause MDR, and to further test the effects of depolarization, we devised a short exposure cytotoxicity assay (see MATERIALS AND METHODS) for control cells not expressing MDR protein but elevated in pHi via growth at different percentages of CO9, or depolarized by exposure to high [K+] o (see Fig. 6 D, inset) . Fig. 8 presents pH i data for LR73 cells grown for 48 h at 5% CO2, followed by 72 h at 10% CO2, and then 72 h more at 5% CO 2. Initial exposure of LR73 cell cultures to higher percentages of CO,, (at fixed HCO 3 in the medium) leads to fast acidification of pHo as reported and concomitant, but not as pronounced, acidification of pH i (Fig. 8) . After pH i plateaus during high percent CO2 "conditioning," and 5% CO2 10% C02 5% CO2
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7.1 x 6.8 pHi _+ 0.04 = 24 hrs FIGURE 8. Alterations in pH i for LR73 cells upon pulsing growing cells with different percentages of CO> Cells were grown as described in methods, pH i was measured for these cells approximately every 24 h in triplicate (at the pH,, of the media under these conditions, see Wei and Roepe [1994] ), and the data averaged (the Xshown in this plot _+0.04 pH U). We note a small yet reproducible transient elevation in pH i for cells at 5% CO 2 after they are stimulated to presumably increase the rate of H + removal via growth under acidic (10% CO2) conditions. Dramatic overexposure of Western and Northern blots reveals that no induction of MDR protein or mRNA expression occurs tinder these conditions (not shown, see Wei and Roepe, 1994) .
assuming the density of the culture is kept subconfluent, the cells "readjust" their pHi homeostasis and nearly recover normal pHi. When these conditioned cells are suddenly transferred back to 5% CO 2 and fresh, pre-equilibrated media is added, pHi "overshoots" for 12-24 h, and theh re-normalizes once again. Thus, a window of alkaline pHi is available for a short period of time in the absence of MDR protein overexpression.
To test whether these alkaline cells were drug resistant, we performed short exposure cytotoxicity assays (see MATERIALS AND METHODS) (Fig. 9, A-C) . Overexposure of Western and Northern blots revealed no increased MDR protein or mRNA overexpression in the cells after manipulating percentage of COe (data not shown, see Wei and Roepe, 1994) . Nonetheless, cells elevated in phi by 0.16-0.24 units did exhibit low, but measurable, resistance to doxorubicin, vincristine, and colchicine. Resistance to doxorubicin and vincristine was higher (approximately four-to fivefold and threeto fourfold, respectively) relative to colchicine resistance (approximately twofold).
The fold-resistance exhibited by these alkaline cells is slightly lower (on average) than the resistance of the two clones exhibiting particularly high levels of hu MDR 1 protein expression (clones #24 and 27, see Table I) yet is comparable to the resistance exhibited by the lower-level expressors. However, we do not measure significant alterations in Vm for CO 2 pulsed cells (data not shown), and a variety of data (reviewed in Roepe, 1995) suggest both decreased Vm and elevated pHi contribute to MDR protein-mediated drug resistance. Thus, one key element of the MDR phenotype is absent for these COz pulsed cells. Also, due to the nature of the assay (see MATERIALS AND METHODS) these levels of resistance may be underestimates.
Similar cytotoxicity assays were performed for LR73 cells resuspended in DME media containing different [K+]o (Fig. 10) . LR73 cells are depolarized (cf., Fig. 6 D, inset) in media containing 15 mM Na+/127 mM K + (dashed lines, Fig. 10 ). Fig. 10 shows these depolarized cells (estimated 25 mV Vm by comparing data in Table I and Fig. 6 to similar diOCs(3) data for cells exposed to high K + DME for similar time, not shown) are also resistant to vincristine (three-to fourfold), doxorubicin (three-to fourfold), and colchicine (~l.5-fold). The resistance is not due to pHi or V~ changes secondary to treatment with high [K+] o (see legend to Fig. 10 ). These data agree with other studies (Wei et al., 1995) that measured mild drug resistance for stably depolarized 3T3/CFTR clones. The results from 3 assays (12 determinations at each drug concentration) were then averaged and are shown +_SE. As demonstrated elsewhere 
Drug Accumulation
Another feature of the MDR phenotype is altered chemotherapeutic drug accumulation. We measured the accumulation of 3H derivatives (see MATERIALS AND METHODS) of anthracycline (Fig. 11, open bars) , vinca alkaloid (dotted bars), and colchicine (solid bars) for two transfectants exhibiting either high (#27) or low (#95) levels of MDR protein overexpression (see Table I ) and compared this accumulation to that exhibited by control kR73/neo transfectants pulse elevated in pHi by the CO 2 pulse method or depolarized in high [K +] medium as described above (Fig. 11) . The two-to threefold levels of drug resistance are essentially mirrored by about twofold lower drug accumulation as measured under these conditions (Fig. 11, open and solid bars) . In contrast, relative accumulation of 3H vinca is more markedly reduced for clone #27 (to ~6% of the level seen in the controls), which is consistent with the comparatively high level of vinca resistance for this cell line (~10-fold) shown in Table I . We emphasize that one should not expect a linear or simple correspondence between fold drug accumulation and fold drug resistance. Even if cells accumulate very similar levels of a weakly basic drug, if that drug is compartmentalized inside the cell in a different fashion (due to, for example, different ApH between cytosolic and vacuolar milieu), the accessibility of the drug to its target may be different, further affecting resistance. Nonetheless, a few general expectations are veri-fled by these results, including that depolarization does not appear to alter accumulation of the uncharged drug colchicine as dramatically as it does the other compounds, although it does appear to have a mild effect (see also Wei et al., 1995) .
DISCUSSION
Which Cellular Alterations Are Unequivocally due to MDR Protein Overexpression ?
Although many studies have previously noted elevated pH i for MDR cells (reviewed in Roepe, 1995) , there has been at least one contrasting observation for a chemotherapeutic drug-selected cell line (Altenberg et al., 1993) in a study that used different techniques, relative to most other work. 5 Along with elevated pHi, several other important biophysical characteristics of MDR cells have been reported, including decreased Vm (Roepe et al., 1993) , altered C1-transport , altered membrane lipid composition (Ramu et al., 1984) , and increased vesicular traffic (Sehested et al., 1987) . It is not difficult to envision how these characteristics might contribute to drug resistance via ~Altenberg et al. (1993) analyzed pH i for populations of 100-150 cells in an atmosphere of 95% ()~ after loading the cells with BCECF-AM for relatively long time (60 rain) in the presence of detergent (the pluronic F-127), techniques which are not followed in other work (I.uz et al., 1994; Roepe et al., 1994; Simon et al., 1994; and this paper) . Fig. 8 , and control transfectants depolarized 25 mV by incubation in DME medium containing 127 mM K + (see MATERIALS AND METH-ODS) as described in Fig. 10 . Daunorubicin and vinblastine were available as less expensive "~H analogues (New England Nuclear and Amersham, respectively). Differences in cell resistance to daunorubicin vs. doxorubicin (which differ by a single OH group) or to vincristine vs. vinblastine (which differ by a single oxygen on the catharanthine group) are not statistically different for the cell lines described (Wei, L.Y., and Roepe, P.D., unpublished data, and see RESULTS) . The most profound alteration in accumulation is for clone #27, which accumulates about 6% of vinca alkaloid, relative to controls.
altering diffusion or partitioning of hydrophobic drugs (Roepe, 1995) , thus it is tempting to conclude that they may be directly or indirectly due to MDR protein overexpression. However, as is the case with elevated phi, a few contrasting observations with respect to these phenotypic features have also been reported (e.g., Ehring et al., 1994; Callaghan et al., 1992) . Therefore, it has been argued that these features might be epiphenomena unrelated to MDR protein overexpression.
In analyzing experiments with MDR cells, it must be emphasized that chemotherapeutic drugs are very powerful compounds. They are not only toxic, but most are mutagenic or even teratogenic, and in certain situations they induce differentiation and other complex phenomena. For example, anthracyclines like doxorubicin form reactive semiquinones and aglycones upon one and two electron reduction, form complexes with iron and other ions, significantly perturb the physical characteristics of membranes, and may even alter critical signal transduction. They alkylate DNA, poison mitochondria, inhibit topoisomerases and other enzymes, and directly modulate second messenger levels, among having other effects. As analysis of MDR protein function has become more detailed, it has therefore become increasingly difficult to separate effects due to MDR protein overexpression from other effects due to drug exposure, and this has dramatically confused interpretation. Although heterologous expression of MDR proteins (e.g., in yeast or bacteria) offers one avenue for improvement, these systems obviously do not accurately model tumor cells, thus important pharmacologic issues cannot be explored. Also, in contrast to some current practices, data collected with heterologous systems need to be interpreted based on expectations that come from the study of pure transfectants, not drug selected MDR cells.
Construction of "True" MDR Transfectants
Therefore, it is crucial that phenotypic alterations unequivocally due to MDR protein overexpression be precisely defined. As described, one convenient way to do this is to study pure MDR 1 transfectants that are not selected or maintained on chemotherapeutic drugs. We have successfully engineered a series of these pure transfectants exhibiting different levels of MDR protein overexpression. Surprisingly, the level of drug resistance exhibited by the clones is much lower than might be expected based on the behavior of drug-selected MDR cells. Our data show that exposure to chemotherapeutic drugs is more important for conferring high (>10-fold) levels of resistance than the MDR protein overexpression that might accompany this exposure. This point is important when considering how extensively MDR protein might alter cellular drug accumulation. That is, a common misconception based on high levels of resistance for drug selected MDR cells is that MDR protein overexpression must somehow lower intracellular levels of drugs by a much larger extent than is the case (Fig. 11 ). Reduced accumulation due to MDR protein can be easily explained by Vm and pH~ perturbations (Wadkins and Roepe, 1996) , and does not require that we invoke a drug pump model Higgins and Gottesman, 1992) .
Many laboratories have had difficulty constructing pure transfectants for reasons that remain vague, but that might be a consequence of relatively poor chromosomal integration of the very large MDR 1 cDNA, or perhaps deleterious effects of the protein. The latter is suggested due to the loss of MDR protein expression for some clones passaged multiple (one to two dozen) times. We could not unequivocally conclude if this was a random or directed genetic event, but clonal selection and the frequency of this phenomenon (Hoffman, M.M., and P.D. Roepe, unpublished data) suggest the later is formally possible. However, this phenomenon could also be due to the cDNA integration context for particular clones. The fact that clones #24 and #27 (as well as several other high-level expressors recently isolated, data not shown) exhibit a stable phenotype argues against a strong selective advantage for low expression under our culture conditions. In any case, since we have isolated several independent high-level overexpressing clones that exhibit a similar and stable phenotype (Table I) at a low but reasonable frequency (see MATERIALS AND METHODS), it is unlikely that we preferentially isolate clones expressing randomly generated MDR 1 mutants.
Characteristics of the Clones and Implications for Multidrug Resistance
These clones exhibit: (a) elevated pHi and altered pHi regulation, (b) lowered V .... (c) low levels of drug resistance that can be explained by the changes in pHi and/ or Vm, and (d) partial reversal of drug resistance by nontoxic levels of verapamil and cyclosporin A. 6 Trends in alkalinization and depolarization are apparent upon plotting these parameters vs. MDR protein expression (Fig. 12) ; however, analysis of more clones is required before these trends should be considered universal. When the sum ofV m and ApH is plotted vs. relative MDR protein overexpression (Fig. 12 C) , a nearly flat line is obtained, as also reported for drug selected myeloma derivatives (Roepe et al., 1993) , indicating the decrease in Vm nearly mirrors the increase in ApH. Importantly, however, since different cells have different mechanisms and priorities for regulating pHi, V .... and volume, different degrees of the changes we have found are likely for different cell types (e.g., cells with high vs. low Na+/H -exchanger activity, or AE 1 vs. AE 2 isoform expression) engineered to overexpress MDR protein.
By comparing Table I to Figs. 8, 9, 10, and 11 and to data recently published elsewhere (Wei et al., 1995) , we propose that changes in Vm and pH~ for the MDR transfectants are sufficient to confer the levels of drug resistance due to MDR protein overexpression. It is unnecessary to invoke a nonspecific drug pump model to explain the MDR protein-mediated MDR phenotype. The pH~/Vm altered partitioning model avoids the significant kinetic, thermodynamic, and specificity difficulties inherent in the drug pump model (Roepe et al., 6The molecular effects of reversal agents are complicated (see Wadkins and Houghton, 1993) , and we will address several of these issues elsewhere (Wei, L.Y., and P.D. Roepe, manuscript in preparation). Interestingly, however, Keizer andJoenje (1989) as well as our own laboratory (Roepe, 1992) previously reported that exposure to verapamil Dowered elevated pH i fi)r MDR cell lines, and the Gnpta laboratory (Vayuvegula et al., 1988) previously reported that either verapamil or cyclosporin A repolarized MDR cells.
1996; Wadkins and Roepe, 1996) . However, several important questions remain. For example, we do not yet know whether pHi and Vm effects are additive or synergistic with respect to drug resistance. It is reasonable to suggest that changes in cytosolic pHi might perturb subcellular distribution of some weakly basic drugs since the ApH across compartmental membranes will also be altered. This effect and others likely have additional impact upon drug partitioning and resistance (see Roepe, 1995; Wadkins and Roepe, 1996) . The sole explanation for drug resistance due to changes in pH~ and Vm is likely not simplified altered equilibrium transmembraneous distribution (e.g., weak base partitioning or altered equilibrium partitioning of cations due to altered Vm). In contrast, MDR is likely due to the sum of several mechanisms acting together. Due to the complexity of chemotherapeutic drug action, which includes cytotoxic and growth inhibitory functions as well as the ability to induce programmed cell death, or apoptosis (interestingly, an apparently pHi-dependent process, see Li and Eastman, 1995; Pdrez-Sala et al., 1995) , we do not necessarily expect simple relationships between drug transport and drug resistance.
Exposure of our cell lines to different chemotherapeutic drugs alters the level of drug resistance and the resistance profile. These results have important implications for studies wherein mutant MDR cDNAs are transfected into cells that are then subsequently grown in the presence of drugs under different conditions relative to cells transfected with wild-type cDNA (see Choi et al., 1988; Gros et al., 1991) . These data have almost always been interpreted to mean that the mutant MDR proteins must pump various drugs with different efficiencies, relative to the wild type, because the drug binding site has been mutated. Alternatively, perhaps the data indicate other (non-MDR protein-mediated) drug resistance mechanisms have been induced with different efficiencies upon the different drug-selection conditions.
Possible Complexities in Interpretation of the Present Data
Since much of our analysis depends upon intracellular probes and since the MDR phenotype is characterized by altered cellular retention of compounds, we are concerned about possible complexities in interpretation. Some investigators propose that fluorometric probes of pH~ and Vm are pumped by the MDR protein and that this pumping function could alter our conclusions. Several arguments suggest this is not the case: (a) Our measurements of loading and leak of BCECF-AM and BCECF, respectively, are in contrast to previous work with drug selected cells (Homolya et al., 1993) . Our data argue that AM derivatives are not pumped by MDR protein and that previous observations that led to this conclusion may be due to drug selection or other 7.6 
Relative MDR Protein
FmURE 12. Relationship between relative MDR protein expression in the series of transt~c-tants and (A) pHi, (B) V,,, (from Table I ), and (C) the mathematical sum of pH and V,,, (in mV, tbllowing the convention that alkaline inside is negative). In A and B the data are fit by a 2nd order polynomial, R'-' > 0.82 in each case.
factors. Even if the compound was somehow pumped, the fact that the different standard curves have similar slope (see Fig. 3 ) shows our calibration in different cell lines is reliable. Via similar arguments, ratiometric measurements with ANEPPS are reliable. (b) Previous analysis of the rate of carbocyanine effiux from MDR vs. sensitive cells showed that there was essentially no difference (Roepe et al., 1993) ; if these compounds were pumped out of the cell by MDR protein there should be an increased rate of effiux (see Roepe, 1992) . (c) Different members of the diOC,(3) series are very similar in chemical structure; much more similar than, for example, vincristine and doxorubicin which, via the pump hypothesis, are both substrates for the pump. Although we cannot completely disprove the notion, it is thus difficult to envision why the putative pump would recognize vincristine, doxorubicin, and diOC5 (3), but not diOC7(3 ). A simpler explanation, also consistent with other data (see Roepe et al., 1993; Luz et al., 1994; Roepe, 1995 ; Table I ), is that the MDR clones have lower Vm-
Future Implications
These data strongly support the altered partitioning model for MDR protein function (Roepe, 1995; Wadkins and Roepe, 1996) , resolve several unsettled pharmacologic issues in the MDR literature, and have important implications for the continued evolution of chemotherapy. Consideration of physical-chemical factors in describing the pharmacology of drugs is almost as old as pharmacology itself; however, appreciation for the extent and manner in which cells and microorganisms can alter physical-chemical effects in the course of developing drug resistance is less well appreciated. Examination of the literature pertaining to other exam-
Analysis q[ True hu MDR1
ples of"ABC-MDR" (i.e., overexpression or mutation of a member of the ABC family thereby conferring pleiotropic drug resistance), for example, pfMDRl-mediated chloroquine resistance in malarial parasites perhaps being accompanied by altered ApH for digestive vacuoles, multidrug resistance-related protein-mediated drug resistance in lung carcinoma perhaps being accompanied by alterations in CI-and K + transport, or the apparent role of V,,, in the CFTR-mediated MDR phenotype (Wei et al., 1995) , leads us to suggest two important possibilities: (a) a general mechanism for how ABC transporters mediate drug resistance may exist through the proteins regulating Vm, pHi, or volume, and (b) other undiscovered pathways to drug resistance may also involve Vm/pH~ perturbations, but via different molecular mechanisms. Indeed, it is interesting to note that the B. subtilis tet B(L) locus (which confers tetracycline resistance) encodes a Na+/H + antiporter (Cheng et al., 1994) and that the sapABCDF complex, which confers resistance to toxic peptides and other compounds in S. typhimurium, regulates K + channel activity (Parra-Lopez et al., 1994) We suggest that a variety of phenomena reported on in the MDR literature should be re-examined with cell lines similar to those used in the present work to determine whether they are unequivocally due to MDR protein overexpression. This point of view is reinforced by considering the levels of drug resistance exhibited by pure MDR transfectants vs. selectants and drug-selected cells; in most reports it is not emphasized that these differ greatly. Also, even if MDR protein overexpression is an important event in the development of a MDR phenotype, other events that occur during continued drug selection likely complicate matters. These might even be important targets for therapy.
